Genomas Gets $1.3M SBIR Grant to Develop Pharmacogenetic Test for Statins

The company will use the grant to further develop its platform to help physicians better manage neuro-myopathy, a common side effect of statin use.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories